Kindstar Global (HKG: 9960), a biopharmaceutical company based in China, has announced a strategic partnership with fellow Chinese firm MGI Tech Co., Ltd. (SHA: 688114). This collaboration will result in the creation of Kindstar’s multi-omics DCS Lab service center, which will be focused on serving the Central China region.
Kindstar is recognized for offering a comprehensive suite of research services spanning genomics, transcriptomics, epigenetics, microbiome, single-cell, spatiotemporal, proteomics, metabolomics, and other omics to the industry. The DCS Lab, a key component of Kindstar’s service offerings, has been successfully implemented across various prestigious institutions. These include the Shanghai Center for Brain Science and Brain-Inspired Technology, the Cell Ecology Haihe Laboratory, and the National Cancer Centre Singapore, among others.- Flcube.com
